Johnson & Johnson (United States)

Type

Company

Country

United States

US

ROR

03qd7mz70

not unique to one org

OpenAlex

I1330063522

the anchor

Documents

57

through any edge

Papers

57

authorship edges

Awards made

Named as funder

Papers

Documents in the 44B Library with Johnson & Johnson (United States) on the authorship, newest first.

2026-07-06 · 5 authors here

Performance evaluation of deep learning models for image analysis: Considerations for visual assessment and statistical metrics

2026-05-28 · 20 authors here

A sustainable platform for federated health data access, AI innovation, and regulatory acceptance in alignment with the European Health Data Space principles

2026-05-28 · 8 authors here

Optimizing post-prostatectomy management: A machine learning tool to identify low-risk patients and minimize unnecessary burden in localized prostate cancer.

2026-05-19 · 10 authors here

O PAPEL DA INTELIGÊNCIA ARTIFICIAL NO DIAGNÓSTICO PRECOCE DE DOENÇAS: DA ANÁLISE DE IMAGEM À TRIAGEM CLÍNICA PREDITIVA

2026-03-30 · 13 authors here

Med.ai ASK: an agentic system for biomedical question answering

2026-03-19 · 12 authors here

Results of the 2025 AMWA Generative AI Member Survey

2026-03-05 · 2 authors here

A Decade of Food and Drug Administration Medical Device Authorizations (2015–2025): Pathway, Specialty, and Artificial Intelligence/Machine Learning Trends

2026-03-01 · 6 authors here

Machine learning for medication error detection: a scoping review protocol

2026-01-28 · 10 authors here

Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 1 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 2 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 5 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 1 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 2 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 3 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 5 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 4 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 3 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2026-01-01 · 10 authors here

Additional file 4 of Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models

2025-12-29 · 19 authors here

The Necessity and Feasibility Assessment Tool of the Clinical Prediction Model for Individual Prognosis Before Its Startup: A Multi‐Sectoral Delphi Consensus Study

2025-12-12 · 10 authors here

Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression

2025-11-24 · 4 authors here

Lessons From One FQHC’s Experience With Artificial Intelligence

2025-11-14 · 14 authors here

A lossless one-shot distributed algorithm for addressing heterogeneity in multi-site generalized linear models

2025-10-31 · 6 authors here

Integrating Ai Chatbots in Customer Service for Credit Card Companies: Enhancing Efficiency and Customer Experience

2025-09-18 · 1 authors here

Artificial Intelligence and Machine Learning in Pharma: Revolutionizing Drug Development and Clinical Trials

Showing 25 of 57 on record.

Funding

Read from the funding tables, never from the document count — that count includes authorship, so it ranks institutions, not funders.

Who funds this work

Funders named on the papers above. The record holds no recipient field, so this is reached through the documents themselves — and the two columns are two different claims, kept apart.

© 2026 NYSGPTLast Updated: August 5, 2026